Handelsbanken Fonder Ab Vericel Corp Transaction History
Handelsbanken Fonder Ab
- $24.3 Billion
- Q1 2025
A detailed history of Handelsbanken Fonder Ab transactions in Vericel Corp stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 20,479 shares of VCEL stock, worth $709,392. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,479
Previous 16,479
24.27%
Holding current value
$709,392
Previous $905,000
0.99%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding VCEL
# of Institutions
294Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$279 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$123 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$97.4 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$85.3 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$84.4 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.63B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...